-

Coronavirus NewsSANBS CEO, Jonathan Louw, donates COVID-19 convalescent plasma

SANBS CEO, Jonathan Louw, donates COVID-19 convalescent plasma
S

With the SARS-CoV-2 infection (COVID-19) now being a part of our reality, the focus is increasingly starting to move towards the development of effective treatments and cures for the virus.

With the SARS-CoV-2 infection (COVID-19) now being a part of our reality, the focus is increasingly starting to move towards the development of effective treatments and cures for the virus.

One of these therapies currently in development is convalescent plasma.

The South African National Blood Service (SANBS) is at the forefront of this therapy in South Africa, currently participating in the collection of convalescent plasma for a national trial.

Heeding the call issued by the SANBS for convalescent plasma, Dr Jonathan Louw, the SANBS Chief Executive Officer has become one of the first people to donate convalescent plasma.

SANBS CEO, Jonathan Louw, donates COVID-19 convalescent plasma
SANBS CEO, Jonathan Louw, donates COVID-19 convalescent plasma

Following what he called a “tough infection, coupled with a history of chronic asthma,” he is happy to have been able to make a full recovery following his intense battle with the infection. 

Dr Louw was one of the early contractors of the COVID-19 virus in the country. Having made a full recovery, he reflected on the effects of the diagnosis.

“I had to go to hospital a couple of times. I was isolated from family for a very long period. It has been a long journey but I’m really hoping that this disease will have a cure soon,” he added.

In the fight against COVID-19, the SANBS is one of a few international blood transfusion services embarking on this exciting research to determine if convalescent plasma, collected from recovered COVID-19 individuals, may help patients hospitalised with COVID-19. Currently there is no proven treatment to improve the outcome for these patients. Convalescent plasma may potentially be one of the only treatment options that works, however this needs to be tested in clinical trials. A convalescent plasma donation is just like a standard plasma donation, the key difference being the need for a specific type of donor.

 “I’ve been a regular donor for many years and through my convalescent plasma that is full of antibodies, I hope I can help someone else,” Louw concluded.

The SANBS is well positioned to collect this product as we already collect a similar product, source plasma, daily.

We have written two research protocols, one to collect the plasma and one to issue the plasma to patients enrolled in a randomised phase 2 placebo-controlled blinded clinical trial.

This is yet another area where we can be trusted to save lives.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

SANBS CEO, Jonathan Louw, donates COVID-19 convalescent plasma

With the SARS-CoV-2 infection (COVID-19) now being a part of our reality, the focus is increasingly starting to move towards the development of effective treatments and cures for the virus.

- Advertisement -

Latest news

Open fires and firebreaks prohibited 2021

That no person shall from Thursday, 06 May 2021 make an open fire in open air, allow it to...

Transvaal Training and Development reach out to the community

Transvaal Training and Development train Police and CPF Transvaal Training and Development reached out to the Trichardt community and trained...

Happy Mothers Day to all mothers

Happy Mothers Day from everyone here at the Bulletin to all our mothers. We hope that honouring this one day...

Kruik se Oggenddiens, 9 Mei 2021

Welkom by kruik se oggenddiens van 9 Mei 2021 Vanoggend se tema: "Wat kan ons leer my Maria se lewe?" https://youtu.be/Vts2NGRl6Vw Die...

You might also likeRELATED
Recommended to you